Home
Explore
Journal Club
Trending
More
synapse
⌘+K
Language
English
English
Mechanistic insights into HAGLROS-mediated therapy resistance in ovarian cancer | Synapse
March 3, 2026
Mechanistic insights into HAGLROS-mediated therapy resistance in ovarian cancer
MS
Mohadeseh Sheykhi-Sabzehpoush
HA
Hamed Abedzeydi
MS
Maryam Khombi Shooshtari
See all
Key Points
HAGLROS is implicated in contributing to therapy resistance in ovarian cancer.
Key evidence shows that targeting HAGLROS may enhance treatment efficacy against ovarian tumors.
Analysis of molecular pathways highlights potential biomarkers for resistance mechanisms.
These findings support the need for novel therapeutic strategies to overcome resistance.
Mark Helpful
Mark Helpful
Save
Bookmark
Relay
Relay
Mark Helpful
Mark Helpful
Save
Bookmark
Relay
Relay
Cite This Study
Copy
Sheykhi-Sabzehpoush et al. (Tue,) studied this question.
synapsesocial.com/papers/69a760adc6e9836116a2da92
https://doi.org/https://doi.org/10.1007/s12094-025-04146-y